标题
Inhibitors of RIP1 kinase: a patent review (2016–present)
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume -, Issue -, Pages 1-15
出版商
Informa UK Limited
发表日期
2020-11-30
DOI
10.1080/13543776.2021.1854729
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- RIP1 kinase activity is critical for skin inflammation but not for viral propagation
- (2020) Joshua D. Webster et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Inhibitors Targeting RIPK1/RIPK3: Old and New Drugs
- (2020) Sofie Martens et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
- (2020) Lauren Mifflin et al. NATURE REVIEWS DRUG DISCOVERY
- RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases
- (2019) Snahel Patel et al. CELL DEATH AND DIFFERENTIATION
- Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase
- (2019) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting RIPK1 for the treatment of human diseases
- (2019) Alexei Degterev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer
- (2019) Philip A. Harris et al. ACS Medicinal Chemistry Letters
- DNL 104, a Centrally Penetrant RIPK 1 Inhibitor, Inhibits RIP 1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers
- (2019) Hendrika W. Grievink et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Necroptosis in the Pathophysiology of Disease
- (2019) Mitri K. Khoury et al. AMERICAN JOURNAL OF PATHOLOGY
- Discovery of 7-Oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure–Kinetic Relationships
- (2018) Masato Yoshikawa et al. JOURNAL OF MEDICINAL CHEMISTRY
- RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
- (2018) Wei Wang et al. CANCER CELL
- Insight into the selective mechanism of phosphoinositide 3-kinase γ with benzothiazole and thiazolopiperidine γ-specific inhibitors by in silico approaches
- (2018) Jingyu Zhu et al. Chemical Biology & Drug Design
- Discovery of a Highly Potent, Selective, and Metabolically Stable Inhibitor of Receptor-Interacting Protein 1 (RIP1) for the Treatment of Systemic Inflammatory Response Syndrome
- (2017) Yan Ren et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
- (2017) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Necroptosis inhibitors as therapeutic targets in inflammation mediated disorders - a review of the current literature and patents
- (2016) Spandana Rajendra Kopalli et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4
- (2016) Malek Najjar et al. IMMUNITY
- DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors
- (2016) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Control of Life-or-Death Decisions by RIP1 Kinase
- (2013) Dana E Christofferson et al. Annual Review of Physiology
- Structural Basis of RIP1 Inhibition by Necrostatins
- (2013) Tian Xie et al. STRUCTURE
- Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis
- (2013) Philip A. Harris et al. ACS Medicinal Chemistry Letters
- Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory disease
- (2012) Mihiro Sunose et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
- (2012) S Jouan-Lanhouet et al. CELL DEATH AND DIFFERENTIATION
- A novel role for RIP1 kinase in mediating TNFα production
- (2012) D E Christofferson et al. Cell Death & Disease
- Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors
- (2011) Noel D. D’Angelo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chromone, a Privileged Scaffold for the Development of Monoamine Oxidase Inhibitors
- (2011) Alexandra Gaspar et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Dual Functions of Receptor Interacting Protein 1 in Fas-Induced Hepatocyte Death During Sepsis
- (2011) Sam I. McNeal et al. SHOCK
- Identification of RIP1 kinase as a specific cellular target of necrostatins
- (2008) Alexei Degterev et al. Nature Chemical Biology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search